Biosimilars: Policy Developments and Emerging Issues
12 PM EDT
Earlier this year, the FTC held a workshop to explore competition issues involving follow-on biologics, also known as biosimilars. This program will follow up on some of the issues raised at the workshop and address recent developments related to the unique challenges that biosimilars present for regulators, policymakers, and drugmakers.
You can attend by phone or in person at Wilson Sonsini Goodrich & Rosati, 1700 K Street NW, Fifth Floor, Washington, D.C.
FREE: Antitrust Section Members, Government, Nonprofit Employees and Students
$25.00: Other non-members
The ABA is not seeking CLE credit for this program.
Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page